You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis

Article metrics

Article menu
Download PDFPDF
ePoster
EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis

 

Online download statistics by month:

Online download statistics by month: November 2019 to April 2024

AbstractFullPdf
Nov 20197001
Dec 20191600
Jan 20202600
Feb 20203701
Mar 20203201
Apr 20201701
May 20203800
Jun 20202002
Jul 20204200
Aug 20202400
Sep 20202000
Oct 20208400
Nov 20207001
Dec 20202300
Jan 20213201
Feb 2021600
Mar 20211800
Apr 2021600
May 2021300
Oct 2021600
Nov 2021800
Dec 2021800
Jan 20223700
Feb 20221000
Mar 2022600
Apr 2022400
May 20221100
Jun 2022800
Jul 20221401
Aug 20221200
Sep 2022900
Oct 2022800
Nov 20221002
Dec 20221200
Jan 2023700
Feb 20231201
Mar 20231800
Apr 2023800
May 2023600
Jun 2023600
Jul 2023800
Aug 2023400
Sep 2023300
Oct 2023400
Nov 20232201
Dec 20232000
Jan 2024600
Feb 2024400
Mar 2024800
Apr 20241000
Total893013